Literature DB >> 17504592

Which test is best for Helicobacter pylori? A cost-effectiveness model using decision analysis.

Glyn Elwyn1, Mark Taubert, Shan Davies, Ginevra Brown, Miles Allison, Ceri Phillips.   

Abstract

GPs face a potential dilemma in deciding which test to use for detection of Helicobacter pylori. For patients with dyspepsia, the National Institute for Health and Clinical Excellence (NICE) advises primary care practitioners to adopt a 'test and treat' policy before considering a referral for gastroscopy. There are many ways of testing: serology, urea breath test, and faecal antigen test. NICE does not advocate any preferred single test for detecting H. pylori. In the current study a multi-stakeholder 2-day workshop was established to agree and populate a cost-effectiveness decision analysis model. The aim was to analyse the three types of tests available for H. pylori and to determine which is the most practical and cost effective. Agreement on the costs and diagnostic values to be entered into the decision-analytic model was achieved. Results indicate that the faecal antigen test was the most effective in terms of true outcomes and cost. One thousand virtual patients were allocated to each of the three tests. Serology had 903, urea breath test had 961, and the faecal antigen test had 968 true positive outcomes. Data indicate that the faecal antigen test is the preferable strategy for diagnosis of H. pylori in primary care. This has implications for implementing new testing processes and for commissioning new diagnostic pathways for use in primary care.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17504592      PMCID: PMC2047016     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  3 in total

1.  Test and treat for dyspepsia--but which test?

Authors:  Cliodna McNulty; Louise Teare; Robert Owen; David Tompkins; Peter Hawtin; Kenneth McColl
Journal:  BMJ       Date:  2005-01-15

2.  The stool antigen test for detection of Helicobacter pylori after eradication therapy.

Authors:  Dino Vaira; Nimish Vakil; Marcello Menegatti; Ben van't Hoff; Chiara Ricci; Luigi Gatta; Giovanni Gasbarrini; Mario Quina; Jose M Pajares Garcia; Arie van Der Ende; Rene van Der Hulst; Marcello Anti; Cristina Duarte; Javier P Gisbert; Mario Miglioli; Guido Tytgat
Journal:  Ann Intern Med       Date:  2002-02-19       Impact factor: 25.391

Review 3.  Which test for Helicobacter pylori in primary care?

Authors: 
Journal:  Drug Ther Bull       Date:  2004-09
  3 in total
  12 in total

1.  A novel line immunoassay based on recombinant virulence factors enables highly specific and sensitive serologic diagnosis of Helicobacter pylori infection.

Authors:  Luca Formichella; Laura Romberg; Christian Bolz; Michael Vieth; Michael Geppert; Gereon Göttner; Christina Nölting; Dirk Walter; Wolfgang Schepp; Arne Schneider; Kurt Ulm; Petra Wolf; Dirk H Busch; Erwin Soutschek; Markus Gerhard
Journal:  Clin Vaccine Immunol       Date:  2013-09-04

Review 2.  Applications of stable isotopes in clinical pharmacology.

Authors:  Reinout C A Schellekens; Frans Stellaard; Herman J Woerdenbag; Henderik W Frijlink; Jos G W Kosterink
Journal:  Br J Clin Pharmacol       Date:  2011-12       Impact factor: 4.335

Review 3.  Cost-effectiveness of the carbon-13 urea breath test for the detection of Helicobacter pylori: an economic analysis.

Authors:  L Masucci; G Blackhouse; R Goeree
Journal:  Ont Health Technol Assess Ser       Date:  2013-10-01

4.  Cost-effectiveness analysis of universal noninvasive testing for post-treatment confirmation of Helicobacter pylori eradication and the impact of patient adherence.

Authors:  Susan H Boklage; Allen W Mangel; Varun Ramamohan; Deirdre Mladsi; Tao Wang
Journal:  Patient Prefer Adherence       Date:  2016-06-08       Impact factor: 2.711

5.  Impact of patient adherence on the cost-effectiveness of noninvasive tests for the initial diagnosis of Helicobacter pylori infection in the United States.

Authors:  Susan H Boklage; Allen W Mangel; Varun Ramamohan; Deirdre Mladsi; Tao Wang
Journal:  Patient Prefer Adherence       Date:  2016-01-21       Impact factor: 2.711

6.  Cost-Effectiveness Analysis of Helicobacter pylori Diagnostic Methods in Patients with Atrophic Gastritis.

Authors:  Fumio Omata; Takuro Shimbo; Sachiko Ohde; Gautam A Deshpande; Tsuguya Fukui
Journal:  Gastroenterol Res Pract       Date:  2017-02-23       Impact factor: 2.260

7.  Recurrent abdominal pain and upper gastrointestinal endoscopy findings in children and adolescents presenting at the Lagos University Teaching Hospital.

Authors:  Oluwafunmilayo Funke Adeniyi; Emuobor Aghoghor Odeghe; Mary Adetola Lawal; Adebambo Olatunde Olowu; Adesoji Ademuyiwa
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

8.  Do non-targeted gastric biopsies affect the management of patients, and can a simple protocol and education reduce the rate?

Authors:  Victoria Gibson; Stephanie Needham; Manu Nayer; Nick P Thompson
Journal:  Frontline Gastroenterol       Date:  2017-08-10

9.  Stool antigen detection versus 13C-urea breath test for non-invasive diagnosis of pediatric Helicobacter pylori infection in a limited resource setting.

Authors:  Mortada El-Shabrawi; Nabil Abd El-Aziz; Tarek Zakaria El-Adly; Fetouh Hassanin; Ayman Eskander; Maha Abou-Zekri; Hala Mansour; Safa Meshaal
Journal:  Arch Med Sci       Date:  2016-07-01       Impact factor: 3.318

10.  Helicobacter pylori in patients with gastritis in West Cameroon: prevalence and risk factors for infection.

Authors:  Nathan E Agbor; Seraphine N Esemu; Lucy M Ndip; Nicoline F Tanih; Stella I Smith; Roland N Ndip
Journal:  BMC Res Notes       Date:  2018-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.